March 6, 2020 / 7:43 AM / 23 days ago

BRIEF-Ryvu Therapeutics Says Phase I Of Clinical Tests Of SEL24/MEN1703 Completed Successfully

March 6 (Reuters) - Ryvu Therapeutics SA:

* SAYS PHASE I FIRST-IN-HUMAN TYPE CLINICAL TESTS OF SEL24/MEN1703 HAVE BEEN COMPLETED SUCCESSFULLY

* SAYS GOAL OF PHASE 1 WAS TO DETERMINE RECOMMENDED DOSE FOR APPLICATION IN PHASE 2

* SAYS MENARINI, WHICH CONDUCTED TESTS, PLANS TO CONTINUE PHASE 2 TESTS Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below